DUBLIN–(BUSINESS WIRE)–The “Patent Strategies for Generic Medicines and Generic Medicine Companies Training Course (Oct 21, 2025)” has been added to ResearchAndMarkets.com’s offering.
In the highly competitive pharmaceutical industry, patent strategies for generic medicines are crucial for success. To successfully bring a generic medicine to market, it is necessary to navigate a complex patent landscape in order to avoid infringing existing patents.
Attending this course will give you a thorough understanding of IP strategies specifically tailored for generic medicines, equipping you with the tools to navigate the complex landscape of pharmaceutical patents and SPCs.
The course will cover how to conduct a robust Freedom to Operate (FTO) analysis to identify and analyse potential patent infringement issues. Drawing on the shared experience of the expert trainers, you will learn to navigate the patent landscape and identify the risks for generic products entering the market.
Acquiring insights into identifying and managing blocking patents, with a focus on when and where to take action, you will understand whether to pursue oppositions or litigation.
It’s crucial to stay updated with the most recent EPO case law, particularly on inventive step as this is the area that has proven to be most successful when challenging patent validity. This will enable you to craft strong arguments for challenging a patent and improve your patent strategy.
Understanding the legal framework surrounding Supplementary Protection Certificates (SPCs) in the EU and UK, will ensure you are fully aware of the specific requirements for these separate IP rights when compared to the patents they are based on. Options for challenging the validity of SPCs based on most recent case law will be explored.
The expert trainers for this course will use case studies and real-world examples to help embed the learning and enhance your practical knowledge. You will leave the course with the understanding and skills to be able to apply these strategies effectively within your own context.
Key topics covered in this course include:
- Comprehensive IP knowledge for generic medicines
- Freedom to operate (FTO)
- Strategic management of blocking patents
- Latest legal insights
- SPC legal landscape
- Practical applications
Benefits of attending
By attending this course, you will:
- Get to grips with the process of Freedom to Operate (FTO) analysis, including assessing potential patent infringement risks and understanding issues around data exclusivity
- Develop the ability to identify and manage blocking patents
- Evaluate whether to pursue oppositions at the EPO or seek revocation of a patent at the new Unified Patent Court (UPC)
- Gain up-to-date knowledge on EPO case law concerning inventive step, and on emerging UPC case law, and how such arguments can be used to challenge the validity of patents
- Understand the legal intricacies and case law of Supplementary Protection Certificates (SPCs), including strategies to challenge their validity
- Learn how to implement these IP strategies in the context of generic medicines, ensuring such products can effectively compete in the pharmaceutical market
Certifications:
- CPD: 6 hours for your records
- Certificate of completion
Who Should Attend:
This course has been specially designed for professionals in generic medicines, including:
- In-house IP and patent lawyers and legal advisers
- Private practice patent lawyers
- IP managers/professionals
- Senior patent administrators and paralegals
- Other professionals responsible for managing a patent portfolio
Course Agenda:
Freedom to operate
- What is ‘Freedom to operate’ analysis?
- Data exclusivity
- Assessing patent infringement
-
Watch out for potential specific patent issues around the following:
- Stereochemistry
- Polymorphs
- New formulations
- Process patents
- Methods of use patents
Problem patents – assessing and managing blocking patents
- Oppositions at the European Patent Office (EPO)
- Litigation at the Unified Patent Court (UPC)
- Oppositions versus litigation – factors in deciding on strategy
- Where to take action? When to take action?
- Successful strategies from case law
The latest updates from UPC and EPO case law: Inventive step
- EPO problem-solution approach to assessing inventive step
- Developing arguments for lack of inventive step
- Impact of emerging UPC case law
Supplementary Protection Certificates (SPCs)
- The EU legal framework
- The UK legal framework
Exploring the validity of SPCs – lessons from the case law
- Questions that arise under Article 3?
- Same or different – EU and UK?
Other aspects arising from SPCs
- Paediatric extensions
- Manufacturing waiver
- Regulatory exclusivities
For more information about this training visit https://www.researchandmarkets.com/r/dckok2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
